Allison M. Glasunow, Ph.D.

Partner

Allison M. Glasunow, Ph.D.

Seattle

Print bio

206.359.3199 direct

AGlasunow@perkinscoie.com

Notice

Before proceeding, please note: If you are not a current client of Perkins Coie, please do not include any information in this e-mail that you or someone else considers to be of a confidential or secret nature. Perkins Coie has no duty to keep confidential any of the information you provide. Neither the transmission nor receipt of your information is considered a request for legal advice, securing or retaining a lawyer. An attorney-client relationship with Perkins Coie or any lawyer at Perkins Coie is not established until and unless Perkins Coie agrees to such a relationship as memorialized in a separate writing.

vCard

Allison builds complex global patent portfolios for breakthrough life sciences companies in highly competitive industries.

Dr. Allison Glasunow counsels clients on technical and legal matters concerning patentability and strategy to develop competitive patent portfolios. She leads clients in due diligence, invalidity, freedom to operate matters, as well as substantively supporting patent litigation cases.

Allison has particular depth in immunotherapy, genetics and genomics, stem cells, cancer therapies, cardiovascular therapies, peptide therapeutics, clinical and research diagnostics, pharmaceuticals, and medical devices, among others.

Specific examples of technologies that Allison has experience with include the following:

Cellular immunotherapy, such as chimeric antigen receptor "CAR" T-cells, antibodies and fragments, and ADC/EDC.
Peptide therapeutics and associated libraries; gene editing technologies, such as CRISPER/Casnucleic acid delivery technologies, such as engineered vectors and sirna/rnai.
Checkpoint inhibitors; sequencing technologies, such as high-throughput sequencing and next generation sequencing.
Fatty acids.
Neurostimulation and neurovascular interventional therapies.

Areas of focus

Industries

Biotechnology & Pharmaceutical

Medical Device

Healthcare

Life Sciences & Healthcare

Services

Patent Prosecution & Portfolio Counseling

Intellectual Property Law

Post-Grant Proceedings

Patent Litigation

Education & Credentials

Education

University of Washington, School of Medicine, Ph.D., Pathology
Seattle Pacific University, B.S., Biology
University of Washington School of Law, J.D.

Bar and Court Admissions

Washington
U.S. Patent and Trademark Office

Related Employment

Sana Biotechnology, Inc., Seattle, WA, Director and Patent Counsel, 2020-2022
Perkins Coie, LLP, Seattle, WA, Associate, 2016-2020
Wilson Sonsini Goodrich & Rosati, Seattle, WA, Patent Agent, 2013-2016

Professional Recognition

Recognized by Best Lawyers: Ones to Watch for Intellectual Property Law, Litigation - Patent, and Patent Law, 2023-2025
Listed in Best Lawyers in America, “Intellectual Property Law, Litigation – Patent, and Patent Law,” 2023-2024

Impact

Professional Leadership

Health Sciences and Services Authority of Spokane County, Spokane, WA, Vice Chair, 2024-2028
Health Sciences and Services Authority of Spokane County, Board Member and Chair of Finance, 2020-present
Sp3NW Governance Advisory Board, 2020-2022
Washington State Patent Law Association, 2015-present
Seattle Intellectual Property Inn of Courts, 2015-2020
Leading Women in Technology, Women in Leadership Program, Alumni Committee, 2017-2020
Women in Biology, Member, 2006-present
South Lake Union Group, Chair; Vice Chair; Treasurer, 2006-2011
North American Association for Vascular Biology, Member, 2006-2011
American Heart Association, Member, 2006-2011

Professional Experience

Biotechnology - Patent Counsel

Private Healthcare Services Organization

Prevailed at the Federal Circuit for private healthcare services organization when the court affirmed that two patents owned by another clinic were invalid for claiming a natural law. The team defended the company against a series of cases and appeals since 2015 and in total, has now invalidated five competing clinic patents and won two Federal Circuit appeals.

BioClin Therapeutics

Provided comprehensive patent counsel for privately held pharmaceutical company developing biologic therapeutics for treatment of FGFR3-mediated conditions. Representation included patent procurement and management of licensed and original patent portfolios.

City of Hope

Provided patent counsel for treatment and research center developing innovative treatments for cancer, diabetes and other diseases. Representation included patent procurement for technologies, including small molecule and biologic therapeutics.

Eloxx Pharmaceuticals

Offered comprehensive patent counsel for publicly traded pharmaceutical company developing small molecule therapeutics for treatment of cystic fibrosis and other premature stop codon-related diseases. Representation included patent procurement and management of licensed and original patent portfolios.

MicroByre

Provided comprehensive IP counsel for privately held biotechnology company developing novel genetically modified bacterial strains. Representation included patent strategy analysis and due diligence.

Olatec Therapeutics, LLC

Represented Olatec Therapeutics, LLC in patent prosecution matters related to methods of using dapansutrile for treatment of cardiovascular disease, including acute myocardial infarction, atherosclerosis, heart failure, stroke, thrombosis, carditis, cardiac allograft rejection, cardiomyopathy and peripheral vascular diseases.

University of Washington CoMotion

Advised University of Washington CoMotion on the preparation and prosecution of patent applications generally directed to: methods of characterizing atherosclerotic plaques; affinity tags and associated processes of purifying tagged molecules; and methods of enhancing nucleic acid amplification by physical proximity.

Public Pharmaceutical Company

Provided outside IP counsel for public pharmaceutical company. Responsible for building and managing global IP strategy for pharmaceutical product with over $150MM in annual sales. Served as IP counsel in domestic and foreign joint development transactions and provided IP counsel in relation to clinical, commercial supply and licensing agreements. Served as IP counsel in due diligence of various product acquisition opportunities.

Emerging Pharmaceutical Company

Provided outside IP counsel for clinical stage pharmaceutical company developing novel compounds for a variety of indications in the fields of dermatology, liver disease and lung disease.

Private Pharmaceutical Company

Provided outside IP counsel for private pharmaceutical company focusing on women’s healthcare, gastroenterology and dermatology in due diligence of various product and company acquisition and licensing opportunities.

Medical Devices - Patent Counsel

Nevro Corporation

Patent portfolio planning, development and counseling, including patent preparation, prosecution, evaluation and analysis for medical device company in the fields of spinal cord stimulation, sensors, and implantable devices.

Ventana Medical Systems, Inc.

Represented Ventana Medical Systems, Inc. in patent prosecution matters related to methods and apparatuses for heating slides, such as for histology.

Zeltiq Aesthetics, Inc.

Counseled Zeltiq Aesthetics, Inc. on patent prosecution matters related to methods, compositions and apparatuses for reducing the freezing point of a patient’s skin and other subcutaneous structures.

ReFlow Medical, Inc.

Advised ReFlow Medical, Inc. in the preparation and prosecution of patent applications generally directed to: catheters for re-entry into a vascular space and associated methods; and drug-eluting stents having protrusions and associated methods.

Medtronic, Plc.

Represented Medtronic, Plc. in the preparation and prosecution of patent applications generally directed to: devices for replacing a patient’s mitral heart valve and associated delivery and removal systems; methods of delivering and/or removing the replacement mitral heart valve to the patient; intrasaccular and/or intravascular occlusive devices or remodeling devices and associated methods of using these devices to treat one or more vascular conditions affecting a patient.

The Brain Protection Company

Advised The Brain Protection Company on strategic analysis, portfolio development and preparation and prosecution of patent applications generally directed to implantable devices for altering blood pressure and/or blood flow in a subject’s brain to treat a cognitive condition, such as dementia, and associated systems and methods.

ReShape Medical, Inc.

Counseled ReShape Medical, Inc. on strategic analysis, portfolio development and preparation and prosecution of patent applications generally directed to: intragastric space fillers, materials for making intragastric space fillers, and associated delivery and removal devices; and associated methods of delivering, placing and/or removing the intragastric space fillers from a patient.

Post-Grant Review/Litigation Support

Horizon Pharmaceuticals, et al. v. Mylan Pharmaceuticals Inc., et al.

U.S. District Court for the District of New Jersey
Providing litigation support to team representing Mylan in three Hatch-Waxman litigations in the District of New Jersey over patent rights to naproxen/esomeprazole magnesium tablets (Vimovo®), used to treat the risk of ulcer formation in patients requiring long-term treatment with non-steroidal anti-inflammatory drugs. Cases are ongoing.

Medical Diagnostic Company

Served as co-counsel in preparation of post-grant review and inter partes review petitions.

Biotechnology and Bio-Diagnostics Company*

Assisted lead counsel in response to inter partes review petitions and for the duration of the inter partes review proceeding, including attending oral arguments.